✨ Your Portfolio is fetched and updated from zerodha.
Micro Miscellaneous

Sunrest Lifescience Ltd.

SUNREST

Market Cap
₹21 Cr.
P/E
10.73

Sunrest Lifescience Ltd.

  • Sunrest Lifescience
  • ACE Men Engg Works
  • Zenlabs Ethica
FAQs on Sunrest Lifescience Ltd. Shareprice

Sunrest Lifescience has given lower returns compared to its competitors.
Sunrest Lifescience has grown at ~-21.18% over the last 1yrs while peers have grown at a median rate of -0.26%

Sunrest Lifescience is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Sunrest Lifescience is 10.73, while 3 year average PE is 67.11.
Also latest EV/EBITDA of Sunrest Lifescience is 12.23 while 3yr average is 11.86.

View FAQ's On Business
Growth Table
  • Sunrest Lifescience Ltd.
  • ACE Men Engg Works
  • Zenlabs Ethica
Balance Sheet
  • Sunrest Lifescience Ltd.
  • ACE Men Engg Works
  • Zenlabs Ethica
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Sunrest Lifescience Ltd.
  • ACE Men Engg Works
  • Zenlabs Ethica
Cash Flow
  • Sunrest Lifescience Ltd.
  • ACE Men Engg Works
  • Zenlabs Ethica
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Sunrest Lifescience Ltd.
  • ACE Men Engg Works
  • Zenlabs Ethica
Quarterly Results
  • Sunrest Lifescience Ltd.
  • ACE Men Engg Works
  • Zenlabs Ethica
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Sunrest Lifescience Ltd. Financials

Balance sheet of Sunrest Lifescience is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Sunrest Lifescience is increasing.
Latest net debt of Sunrest Lifescience is ₹10.31 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹5.79 Crs.

The profit is oscillating.
The profit of Sunrest Lifescience is ₹2.57 Crs for TTM, ₹0.23 Crs for Mar 2024 and ₹2.04 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Sunrest Lifescience latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech